Immunogenicity and reactogenicity of trivalent influenza subunit vaccine Influvac (Rm) for the season 2006/2007. An open, baseline-controlled study in two groups of healthy subjects: Adults and elderly

Trial Profile

Immunogenicity and reactogenicity of trivalent influenza subunit vaccine Influvac (Rm) for the season 2006/2007. An open, baseline-controlled study in two groups of healthy subjects: Adults and elderly

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Jun 2013

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors Solvay Pharmaceuticals
  • Most Recent Events

    • 21 Sep 2007 Status changed from in progress to completed.
    • 16 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top